
|Articles|May 26, 2016
Cenduit Announces Upgraded Patient Reminders Tool
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, announced the release of its upgraded Patient Reminders tool.
Advertisement
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, announced the release of its upgraded Patient Reminders tool. The upgraded features of this tool include a two-way messaging dashboard and a mobile app compatible with iPhone and Android devices.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: De-Identified RWE Gains Ground, HHS Funding Stabilizes Research, and US Finalizes WHO Exit
2
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
3
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
4
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
5




